MYLAN 1730 MYLAN 1730 (Ursodiol 300 mg)
Pill imprint MYLAN 1730 MYLAN 1730 has been identified as Ursodiol 300 mg.
Ursodiol is used in the treatment of biliary cirrhosis; nonalcoholic fatty liver disease; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 1730 MYLAN 1730
- Strength:
- 300 mg
- Color:
- Peach & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Gallstone solubilizing agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1730
- Inactive Ingredients:
- silicon dioxide
corn starch
FD&C Yellow No. 6
gelatin
hydroxypropyl cellulose
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide
ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
shellac
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0383 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about ursodiol
Consumer resources
- Other brands: Actigall, Urso, Urso Forte
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
